Cardiovascular Effects of Marathon Running (FEIDIPIDIS)

November 14, 2023 updated by: Evangelia Kouidi, Aristotle University Of Thessaloniki

FEIDIPIDIS Study: Cardiovascular Effects of Marathon Running

The aim of this study is the investigation of acute cardiovascular responses of marathon runners after the completion of a marathon race (42.2 km), as well as of the determinants of these changes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Greece
      • Thessaloníki, Greece
        • Aristotle University Of Thessaloniki

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Marathon runners aiming to paricipate in a marathon running race

Description

Inclusion Criteria:

  • Marathon runner

Exclusion Criteria:

  • Chronic disease, Drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline left ventricular (LV) systolic function
Time Frame: Evaluation of athletes within 3 weeks before the marathon running race.
Evaluation of LV ejection fraction
Evaluation of athletes within 3 weeks before the marathon running race.
Baseline LV diastolic function
Time Frame: Evaluation of athletes within 3 weeks before the marathon running race.
Evaluation of LV filling pressures
Evaluation of athletes within 3 weeks before the marathon running race.
Baseline basal right ventricular (RV) function
Time Frame: Evaluation of athletes within 3 weeks before the marathon running race.
Evaluation of tricuspid annular plane systolic excursion (TAPSE)
Evaluation of athletes within 3 weeks before the marathon running race.
Baseline global RV function
Time Frame: Evaluation of athletes within 3 weeks before the marathon running race.
Evaluation of RV fractional are change (RVFAC)
Evaluation of athletes within 3 weeks before the marathon running race.
Post-exercise LV systolic function
Time Frame: Evaluation of athletes immediately after the completion of the marathon running race.
Evaluation of LV ejection fraction
Evaluation of athletes immediately after the completion of the marathon running race.
Post-exercise LV diastolic function
Time Frame: Evaluation of athletes immediately after the completion of the marathon running race.
Evaluation of LV filling pressures
Evaluation of athletes immediately after the completion of the marathon running race.
Post-exercise basal RV function
Time Frame: Evaluation of athletes immediately after the completion of the marathon running race.
Evaluation of TAPSE
Evaluation of athletes immediately after the completion of the marathon running race.
Post-exercise global RV function
Time Frame: Evaluation of athletes immediately after the completion of the marathon running race.
Evaluation of RVFAC
Evaluation of athletes immediately after the completion of the marathon running race.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aristotle University Of Thessaloniki

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2021

Primary Completion (Actual)

August 30, 2021

Study Completion (Actual)

August 30, 2021

Study Registration Dates

First Submitted

January 27, 2021

First Submitted That Met QC Criteria

January 31, 2021

First Posted (Actual)

February 4, 2021

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 14, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • EC-3/2020

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Athletes Heart

Clinical Trials on Body fat measurement

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe